Venkata Siva Kumar Pajjuru, MD
Cardiovascular Disease · Yankton, SDNPI 1720565831
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.6%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 92.9% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $2,880, more than ten times the $268 reported in 2021.
Across 58 payments — averaging $120.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Astellas Pharma US Inc$170
- Edwards Lifesciences$153
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$71
- Abbott$34
- Abiomed$27
- plus $40 from 3 others
What the payments were for
- Travel & lodging$4,08259%
- Food & beverage$2,71439%
- Education$1702%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 48 | $6,471 |
| Astellas Pharma US Inc | 2 | $170 |
| Edwards Lifesciences | 1 | $153 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $71 |
| Abbott | 2 | $34 |
| Abiomed | 1 | $27 |
| Johnson & Johnson | 1 | $15 |
| Teleflex LLC | 1 | $13 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,966 in reported general payments places this provider in the 80th percentile of 33 cardiovascular disease providers in South Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 19 | $22,486 |
| EliquisApixaban | 12 | $11,424 |
| Atorvastatin Calcium | 24 | $390 |
| Metoprolol Succinate | 31 | $282 |
| Metoprolol Tartrate | 17 | $158 |
| Amiodarone Hcl | 12 | $117 |
| Ezetimibe | 14 | $115 |
| Losartan Potassium | 11 | $100 |
| Rosuvastatin Calcium | 14 | $80 |
| Spironolactone | 16 | $57 |
| Furosemide | 17 | $55 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Yankton
- Timothy IrwinYankton$500
- Bhaskar PurushottamRapid City$151K
- Naveen RajpurohitSioux Falls$68K
- Kevin VaskaSioux Falls$24K
- Udit BhatnagarSioux Falls$19K
- John BacharachSioux Falls$18K
- Mahmoud SharafSioux Falls$11K
- K HeilmanRapid City$5K
- Alexander SchabauerRapid City$4K
- Maria StysSioux Falls$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.